National Health Investors - NHI Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" NHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View NHI analyst ratings or view top-rated stocks.

4 equities research analysts have issued twelve-month price objectives for National Health Investors' shares. Their NHI share price forecasts range from $58.00 to $64.00. On average, they expect the company's share price to reach $61.25 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price.
View analysts price targets for NHI or view top-rated stocks among Wall Street analysts.

National Health Investors' stock was trading at $52.22 at the beginning of the year. Since then, NHI shares have increased by 13.3% and is now trading at $59.17.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our NHI earnings forecast.

National Health Investors will be holding an earnings conference call on Wednesday, February 22nd at 12:00 PM Eastern. Interested parties can register for or listen to the call using this link.

National Health Investors, Inc. (NYSE:NHI) announced its earnings results on Monday, May, 9th. The real estate investment trust reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.63 by $0.45. The real estate investment trust earned $71.33 million during the quarter, compared to the consensus estimate of $73.06 million. National Health Investors had a net margin of 25.62% and a trailing twelve-month return on equity of 4.96%. National Health Investors's quarterly revenue was down 11.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.24 EPS.

National Health Investors announced a quarterly dividend on Tuesday, November 8th. Investors of record on Friday, December 30th will be paid a dividend of $0.90 per share on Friday, January 27th. This represents a $3.60 annualized dividend and a dividend yield of 6.08%. The ex-dividend date is Thursday, December 29th.
Read our dividend analysis for NHI.

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 6.04%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 229.30%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 79.65% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

National Health Investors issued an update on its FY 2022 earnings guidance on Thursday, December, 8th. The company provided earnings per share (EPS) guidance of $3.86-$3.92 for the period. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

National Health Investors' stock is owned by a number of institutional and retail investors. Top institutional investors include Lasalle Investment Management Securities LLC (0.73%), Sumitomo Mitsui Trust Holdings Inc. (0.65%), Lee Danner & Bass Inc. (0.21%), Nepsis Inc. (0.12%), Shilanski & Associates Inc. (0.11%) and DekaBank Deutsche Girozentrale (0.10%). Insiders that own company stock include D Eric Mendelsohn, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends.

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NHI stock can currently be purchased for approximately $59.17.

National Health Investors (NYSE:NHI) has a market capitalization of $2.57 billion and generates $277.19 million in revenue each year. The real estate investment trust earns $111.80 million in net income (profit) each year or $1.57 on an earnings per share basis.

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The official website for the company is www.nhireit.com. The real estate investment trust can be reached via phone at (615) 890-9100, via email at investorrelations@nhireit.com, or via fax at 615-225-3030.